RECRUITING

Cutaneous Hydration Assessment in SCD

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study will validate the diagnostic accuracy of a cutaneous hydration sensor. This sensor will also be evaluated for its feasibility as a point-of-care device for the assessment of hydration status and its potential to guide hydration therapy in patients with sickle cell disease (SCD).

Official Title

Cutaneous Hydration Assessment in Sickle Cell Disease

Quick Facts

Study Start:2022-01-21
Study Completion:2026-10-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05210114

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:12 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Diagnosis of Sickle Cell Disease (genotypes SS, SC, Sß-thalassemia, SD, SOArab)
  2. * Participants must be ≥12-years old
  3. * Participants that provide legally effective consent to all study procedures
  1. * Participants under 12-years old
  2. * Participants being treated with experimental therapies in clinical trials

Contacts and Locations

Study Contact

Enrico Novelli, MD
CONTACT
412-916-3416
noveex@upmc.edu
Manzoor Mohideen, PhD
CONTACT
412-648-6920
mohideenm@upmc.edu

Principal Investigator

Enrico Novelli, MD
PRINCIPAL_INVESTIGATOR
University of Pittsburgh

Study Locations (Sites)

UPMC Sickle Cell Clinic
Pittsburgh, Pennsylvania, 15213
United States

Collaborators and Investigators

Sponsor: Enrico Novelli

  • Enrico Novelli, MD, PRINCIPAL_INVESTIGATOR, University of Pittsburgh

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-01-21
Study Completion Date2026-10-31

Study Record Updates

Study Start Date2022-01-21
Study Completion Date2026-10-31

Terms related to this study

Additional Relevant MeSH Terms

  • Sickle Cell Disease